Side effects included [[nausea]], vomiting, [[insomnia]], loss of appetite, increased [[erythrocyte]] sedimentation, [[electrocardiogram|EKG]] and [[electroencephalogram|EEG]] anomalies, [[epigastric pain]], diarrhea, [[constipation]], [[Vertigo (medical)|vertigo]], [[hypotension|orthostatic hypotension]], [[edema]] of the lower extremities, [[dysarthria]], [[tremor]], psychomotor agitation, mental confusion, inappropriate secretion of [[antidiuretic hormone]], increased [[transaminase]]s, [[seizure]], (there were three cases worldwide, and most animal studies (and clinical trials that included [[epilepsy]] patients) indicated the presence of ''anti''convulsant properties, so was not completely contraindicated in epilepsy,<ref name=seizure_risk>{{cite journal |vauthors=Edwards JG, Glen-Bott M |title=Does viloxazine have epileptogenic properties? |journal=Journal of Neurology, Neurosurgery, and Psychiatry |volume=47 |issue=9 |pages=960–4 |date=September 1984 |pmid=6434699 |pmc=1027998 |doi=10.1136/jnnp.47.9.960}}</ref>) and increased libido.<ref name=Chebili_et_al_1998>{{cite journal |vauthors=Chebili S, Abaoub A, Mezouane B, Le Goff JF |trans_title=Antidepressants and sexual stimulation: the correlation |language=French |journal=L'Encéphale |volume=24 |issue=3 |pages=180–4 |year=1998 |pmid=9696909 |title=Antidepressants and sexual stimulation: the correlation}}</ref>

 

